| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.32 | 0.04 |